Detalles de la búsqueda
1.
Comparison of the pharmacokinetic and pharmacodynamic properties of two recombinant granulocyte colony-stimulating factor formulations after single subcutaneous administration to healthy volunteers.
Medicina (Kaunas)
; 50(3): 144-9, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25323541
2.
Three-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I/IIa Clinical Trial, Cohorts 1-5.
Am J Ophthalmol
; 240: 285-301, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35248547
3.
An open-label multicenter safety, tolerability, and efficacy study of recombinant granulocyte colony-stimulating factor in the prevention of neutropenic complications in breast cancer patients.
Medicina (Kaunas)
; 47(8): 428-33, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22123557
Resultados
1 -
3
de 3
1
Próxima >
>>